TY - JOUR
T1 - Delays in Follow-up Care for Abnormal Mammograms in Mobile Mammography Versus Fixed-Clinic Patients
AU - Vang, Suzanne S.
AU - Dunn, Alexandra
AU - Margolies, Laurie R.
AU - Jandorf, Lina
N1 - Funding Information:
Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number T32CA225617. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2021, Society of General Internal Medicine.
PY - 2022/5
Y1 - 2022/5
N2 - Background: Mobile mammographic services (MM) have been shown to increase breast cancer screening in medically underserved women. However, little is known about MM patients’ adherence to follow-up of abnormal mammograms and how this compares with patients from traditional, fixed clinics. Objectives: To assess delays in follow-up of abnormal mammograms in women screened using MM versus fixed clinics. Design: Electronic medical record review of abnormal screening mammograms. Subjects: Women screened on a MM van or at a fixed clinic with an abnormal radiographic result in 2019 (N = 1,337). Main Measures: Our outcome was delay in follow-up of an abnormal mammogram of 60 days or greater. Guided by Andersen’s Behavioral Model of Health Services Utilization, we assessed the following: predisposing (age, ethnicity, marital status, preferred language), enabling (insurance, provider referral, clinic site), and need (personal breast cancer history, family history of breast/ovarian cancer) factors. Key Results: Only 45% of MM patients had obtained recommended follow-up within 60 days of an abnormal screening compared to 72% of fixed-site patients (p <.001). After adjusting for predisposing, enabling, and need factors, MM patients were 2.1 times more likely to experience follow-up delays than fixed-site patients (CI: 1.5–3.1; p <.001). African American (OR: 1.5; CI: 1.0–2.1; p <.05) and self-referred (OR: 1.8; CI: 1.2–2.8; p <.01) women were significantly more likely to experience delays compared to Non-Hispanic White women or women with a provider referral, respectively. Women who were married (OR: 0.63; CI: 0.5–0.9; p <.01), had breast cancer previously (OR: 0.37; CI: 0.2–0.8; p <.05), or had a family history of breast/ovarian cancer (OR: 0.76; CI: 0.6–0.9; p <.05) were less likely to experience delayed care compared to unmarried women, women with no breast cancer history, or women without a family history of breast/ovarian cancer, respectively. Conclusions: A substantial proportion of women screened using MM had follow-up delays. Women who are African American, self-referred, or unmarried are particularly at risk of experiencing delays in care for an abnormal mammogram.
AB - Background: Mobile mammographic services (MM) have been shown to increase breast cancer screening in medically underserved women. However, little is known about MM patients’ adherence to follow-up of abnormal mammograms and how this compares with patients from traditional, fixed clinics. Objectives: To assess delays in follow-up of abnormal mammograms in women screened using MM versus fixed clinics. Design: Electronic medical record review of abnormal screening mammograms. Subjects: Women screened on a MM van or at a fixed clinic with an abnormal radiographic result in 2019 (N = 1,337). Main Measures: Our outcome was delay in follow-up of an abnormal mammogram of 60 days or greater. Guided by Andersen’s Behavioral Model of Health Services Utilization, we assessed the following: predisposing (age, ethnicity, marital status, preferred language), enabling (insurance, provider referral, clinic site), and need (personal breast cancer history, family history of breast/ovarian cancer) factors. Key Results: Only 45% of MM patients had obtained recommended follow-up within 60 days of an abnormal screening compared to 72% of fixed-site patients (p <.001). After adjusting for predisposing, enabling, and need factors, MM patients were 2.1 times more likely to experience follow-up delays than fixed-site patients (CI: 1.5–3.1; p <.001). African American (OR: 1.5; CI: 1.0–2.1; p <.05) and self-referred (OR: 1.8; CI: 1.2–2.8; p <.01) women were significantly more likely to experience delays compared to Non-Hispanic White women or women with a provider referral, respectively. Women who were married (OR: 0.63; CI: 0.5–0.9; p <.01), had breast cancer previously (OR: 0.37; CI: 0.2–0.8; p <.05), or had a family history of breast/ovarian cancer (OR: 0.76; CI: 0.6–0.9; p <.05) were less likely to experience delayed care compared to unmarried women, women with no breast cancer history, or women without a family history of breast/ovarian cancer, respectively. Conclusions: A substantial proportion of women screened using MM had follow-up delays. Women who are African American, self-referred, or unmarried are particularly at risk of experiencing delays in care for an abnormal mammogram.
KW - abnormal mammogram
KW - breast cancer
KW - mobile mammography
KW - screening
KW - underserved
UR - http://www.scopus.com/inward/record.url?scp=85125226058&partnerID=8YFLogxK
U2 - 10.1007/s11606-021-07189-3
DO - 10.1007/s11606-021-07189-3
M3 - Article
C2 - 35212876
AN - SCOPUS:85125226058
VL - 37
SP - 1619
EP - 1625
JO - Journal of General Internal Medicine
JF - Journal of General Internal Medicine
SN - 0884-8734
IS - 7
ER -